Cargando…
Genetic Contribution to the Pathogenesis of Primary Biliary Cholangitis
Formerly termed primary biliary cirrhosis, primary biliary cholangitis (PBC) is a chronic and progressive cholestatic liver disease characterized by the presence of antimitochondrial antibodies. Ursodeoxycholic acid (UDCA) therapy is the most effective and approved treatment for PBC and leads to a f...
Autores principales: | Joshita, Satoru, Umemura, Takeji, Tanaka, Eiji, Ota, Masao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5309396/ https://www.ncbi.nlm.nih.gov/pubmed/28255561 http://dx.doi.org/10.1155/2017/3073504 |
Ejemplares similares
-
Genetic Association of PTPN22 Polymorphisms with Autoimmune Hepatitis and Primary Biliary Cholangitis in Japan
por: Umemura, Takeji, et al.
Publicado: (2016) -
Serum Autotaxin Is a Useful Disease Progression Marker in Patients with Primary Biliary Cholangitis
por: Joshita, Satoru, et al.
Publicado: (2018) -
Prognostic utility of albumin-bilirubin grade in Japanese patients with primary biliary cholangitis
por: Yamashita, Yuki, et al.
Publicado: (2022) -
Serum Cell Death Biomarkers for Prediction of Liver Fibrosis and Poor Prognosis in Primary Biliary Cirrhosis
por: Sekiguchi, Tomohiro, et al.
Publicado: (2015) -
A cis-eQTL of HLA-DPB1 Affects Susceptibility to Type 1 Autoimmune Hepatitis
por: Yamazaki, Tomoo, et al.
Publicado: (2018)